Aterian, Inc. (ATER)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue Quarterly

0 25M 50M 75M Q3 '21: 68.1M Q4 '21: 63.3M Q1 '22: 41.7M Q2 '22: 58.3M Q3 '22: 66.3M Q4 '22: 54.9M Q1 '23: 34.9M Q2 '23: 35.3M Q3 '23: 39.7M Q4 '23: 32.8M Q1 '24: 20.2M Q2 '24: 28M Q3 '24: 26.2M Q4 '24: 24.6M Q1 '25: 63K Q2 '25: 88K Q3 '25: 19M Q4 '25: 15.1M Q1 '26: 18K Q2 '26: 7K Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Gross Profit Quarterly

0 15M 30M 45M Q3 '21: 34.2M Q4 '21: 28.9M Q1 '22: 23.6M Q2 '22: 31.4M Q3 '22: 30.2M Q4 '22: 20.4M Q1 '23: 19.1M Q2 '23: 14.9M Q3 '23: 19.6M Q4 '23: 16.7M Q1 '24: 13.2M Q2 '24: 16.9M Q3 '24: 15.8M Q4 '24: 15.6M Q1 '25: 50K Q2 '25: 41K Q3 '25: 10.7M Q4 '25: 8.5M Q1 '26: 10K Q2 '26: 1K Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Operating Income Quarterly

-120M -80M -40M 0 40M 80M 120M Q3 '21: -7.5M Q4 '21: -3.3M Q1 '22: -36.3M Q2 '22: -10.1M Q3 '22: -108.9M Q4 '22: -22.8M Q1 '23: -25M Q2 '23: -36.4M Q3 '23: -6.5M Q4 '23: -8.2M Q1 '24: -5.3M Q2 '24: -3.2M Q3 '24: -1.7M Q4 '24: -1.6M Q1 '25: -3.3M Q2 '25: -3.6M Q3 '25: -2M Q4 '25: -7.7M Q1 '26: -3.2M Q2 '26: -4M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Net Income Quarterly

-120M -80M -40M 0 40M 80M 120M Q3 '21: -110.6M Q4 '21: -6.6M Q1 '22: -42.8M Q2 '22: -16.3M Q3 '22: -116.9M Q4 '22: -20.3M Q1 '23: -25.8M Q2 '23: -34.8M Q3 '23: -6.3M Q4 '23: -7.7M Q1 '24: -5.2M Q2 '24: -3.6M Q3 '24: -1.8M Q4 '24: -1.3M Q1 '25: -3.9M Q2 '25: -4.9M Q3 '25: -2.3M Q4 '25: -7.9M Q1 '26: -6.1M Q2 '26: -491K Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Cost of Revenue Quarterly

0 15M 30M 45M Q3 '21: 33.9M Q4 '21: 34.4M Q1 '22: 18.1M Q2 '22: 26.9M Q3 '22: 36.1M Q4 '22: 34.5M Q1 '23: 15.8M Q2 '23: 20.4M Q3 '23: 20.1M Q4 '23: 16M Q1 '24: 7M Q2 '24: 11.1M Q3 '24: 10.4M Q4 '24: 9M Q1 '25: 13K Q2 '25: 47K Q3 '25: 8.3M Q4 '25: 6.6M Q1 '26: 8K Q2 '26: 6K Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Operating Cash Flow Quarterly

-15M -10M -5M 0 5M 10M 15M Q3 '21: -7.6M Q4 '21: -1.5M Q1 '22: -13.2M Q2 '22: -8.9M Q3 '22: 2.6M Q4 '22: 2.1M Q1 '23: -7.4M Q2 '23: -1.4M Q3 '23: 399K Q4 '23: -4.9M Q1 '24: -6K Q2 '24: 2.9M Q3 '24: -722K Q4 '24: -9K Q1 '25: -3.9M Q2 '25: -4.4M Q3 '25: -1.6M Q4 '25: -1M Q1 '26: -363K Q2 '26: 438K Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Free Cash Flow Quarterly

-27M -18M -9M 0 9M 18M 27M Q4 '20: -1.6M Q1 '21: -8.5M Q2 '21: -24.4M Q3 '21: -7.6M Q4 '21: -1.5M Q4 '22: 2M Q1 '23: -7.5M Q2 '23: -1.5M Q3 '23: 385K Q4 '23: -5M Q1 '24: -42K Q2 '24: 2.9M Q3 '24: -722K Q4 '24: -9K Q1 '25: -3.9M Q2 '25: -4.4M Q3 '25: -1.6M Q4 '25: -1M Q1 '26: -367K Q2 '26: 424K Q1 '21 Q4 '21 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 30M 60M 90M Q2 '21: 29.5M Q3 '21: 35.4M Q1 '22: 55.1M Q2 '22: 63.9M Q3 '22: 64.6M Q1 '23: 76.7M Q2 '23: 77.6M Q3 '23: 6.6M Q1 '24: 6.8M Q2 '24: 7M Q3 '24: 7.2M Q1 '25: 7.5M Q2 '25: 7.7M Q3 '25: 8.2M Q1 '26: 8.8M Q2 '26: 9.2M Q3 '21 Q2 '22 Q1 '23 Q3 '23 Q2 '24 Q1 '25 Q3 '25 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-10.50 -7.00 -3.50 0.00 3.50 7.00 10.50 Q3 '21: -10.01 Q4 '21: -6.67 Q1 '22: -4.30 Q2 '22: -3.33 Q3 '22: -2.01 Q4 '22: -3.02 Q1 '23: -2.58 Q2 '23: -2.77 Q3 '23: -1.91 Q4 '23: -2.87 Q1 '24: -3.29 Q2 '24: -3.36 Q3 '24: -2.66 Q4 '24: -1.70 Q1 '25: -1.46 Q2 '25: -1.57 Q3 '25: -1.60 Q4 '25: -2.40 Q1 '26: -2.57 Q2 '26: -1.99 Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.